Skip to content

AI-driven Automated Biomedical Research

A Study on Artificial Intelligence-based Automated Biomedical Research

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06962423
Enrollment
40
Registered
2025-05-08
Start date
2025-05-15
Completion date
2026-05-15
Last updated
2025-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence (AI), Biomedical Research

Brief summary

This study will evaluate the effects of the AI system developed by our team on biomedical research.

Detailed description

It i a randomized-controlled study. Participants will be randomly assigned to the Intervention Group using our AI system and the Control Group. Both groups will perform the same biomedical research tasks and submit reports. At the end of the study, the research performance of the two groups will be evaluated.

Interventions

Participants will complete the research task with the AI system developed by out team to perform automated biomedical research.

Sponsors

Tsinghua University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* (1) Age ≥ 18 years old; * (2) Agree to sign consent form and invest time in this study; * (3) Able to understand and complete research tasks.

Exclusion criteria

* (1) Currently participating in other projects that may interfere with this research and unable to ensure participation time; * (2) Have a history of major diseases or poor physical condition in the past three months that may affect research participation; * (3) Unwilling or unable to understand and complete the research tasks.

Design outcomes

Primary

MeasureTime frameDescription
Research quality evaluation scaleThrough study completion, an average of 1 weekIndependent senior experts will evaluate the research reports from the Intervention Group and the Control Group using a standardized 100-point Research Quality Evaluation Scale. A higher score indicates better research quality.

Secondary

MeasureTime frameDescription
Model performanceThrough study completion, an average of 1 weekThe diagnostic accuracy, sensitivity, specificity, and area under the receiver-operating characteristic curve (AUC-ROC) will be reported to compare the performance of models generated by the Intervention Group and the Control Group.
Research time costThrough study completion, an average of 1 weekThe time spent by the Intervention Group and the Control Group to complete tasks will be compared.
User evaluationThrough study completion, an average of 1 weekUser evaluation on the study will be assessed by Likert Scales.
Model resource consumptionThrough study completion, an average of 1 weekGPU usage rate and time and model size will be tracked and compared to evaluate the computational resource consumption of the Intervention Group and Control Group.

Countries

China

Contacts

Primary ContactJunxian Hong
hongjx17@mails.tsinghua.edu.cn+86 18800129260
Backup ContactWenquan Cheng
chengwq24@mails.tsinghua.edu.cn+86 15385706612

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026